Noah Goodman Kymera Therapeutics, Inc. (KYMR) insider trading activity
Noah Goodman is Chief Business Officer of Kymera Therapeutics, Inc.. Currently has a direct ownership of 50,081 shares of KYMR, which is worth approximately $2.21 Million. The most recent transaction as insider was on Apr 08, 2025, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
50.1K
n/a
3M change
n/a
12M change
Total Value Held
$2.21 Million
NG
Noah Goodman
Chief Business Officer
Watertown, MA